| 2024-04-22 19:37 | CC:KNE | Kane Biotech Inc (2) | 0.14 | Property Agreement315 | Kane Biotech sale of Stem Animal interest |
| 2024-04-16 15:23 | CC:KNE | Kane Biotech Inc (2) | 0.14 | News Release200 | Kane Biotech to hold webinar April 18 |
| 2024-04-15 14:44 | CC:KNE | Kane Biotech Inc (2) | 0.125 | News Release200 | Kane Biotech closes STEM interest sale |
| 2024-04-11 10:02 | CC:KNE | Kane Biotech Inc (2) | 0.15 | News Release200 | Kane Biotech signs agreement in principle for Stem sale |
| 2024-04-11 09:55 | CC:KNE | Kane Biotech Inc (2) | 0.15 | Resume Trading385 | Kane Biotech to resume at 7:30 a.m. PT |
| 2024-04-11 08:56 | CC:KNE | Kane Biotech Inc (2) | 0.15 | Halt Trading170 | Kane Biotech halted at the open |
| 2024-03-26 16:33 | CC:KNE | Kane Biotech Inc (2) | 0.105 | News Release200 | Kane Biotech loses $5.27-million in 2023 |
| 2024-03-26 16:28 | CC:KNE | Kane Biotech Inc (2) | 0.105 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-03-26 16:21 | CC:KNE | Kane Biotech Inc (2) | 0.105 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-03-20 11:25 | CC:KNE | Kane Biotech Inc (2) | 0.105 | News Release200 | Kane extends exclusivity period on Stem offer |
| 2024-03-19 16:14 | CC:KNE | Kane Biotech Inc (2) | 0.105 | News Release200 | Kane Biotech to release 2023 results March 26 |
| 2024-02-22 13:11 | CC:KNE | Kane Biotech Inc (2) | 0.095 | News Release200 | Kane Biotech appoints Huizinga as executive chair |
| 2024-01-31 12:03 | CC:KNE | Kane Biotech Inc (2) | | News Release200 | Kane Biotech files revyve wound gel spray patent |
| 2024-01-18 16:34 | CC:KNE | Kane Biotech Inc (2) | 0.085 | News Release200 | Kane Biotech to hold special meeting Feb. 20 |
| 2023-12-28 16:12 | CC:KNE | Kane Biotech Inc (2) | 0.085 | News Release200 | Kane Biotech extends Pivot credit line to March 31 |
| 2023-12-20 11:40 | CC:KNE | Kane Biotech Inc (2) | 0.075 | News Release200 | Kane Biotech to sell interest in STEM Animal Health |
| 2023-11-28 16:24 | CC:KNE | Kane Biotech Inc (2) | 0.075 | News Release200 | Kane Biotech loses $1.44-million in Q3 |
| 2023-11-28 16:22 | CC:KNE | Kane Biotech Inc (2) | 0.075 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-28 16:20 | CC:KNE | Kane Biotech Inc (2) | 0.075 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-11-21 12:21 | CC:KNE | Kane Biotech Inc (2) | 0.055 | News Release200 | Kane Biotech to release Q3 2023 results Nov. 28 |
| 2023-11-16 14:56 | CC:KNE | Kane Biotech Inc (2) | 0.06 | News Release200 | Kane Biotech appoints Coleman as director |
| 2023-11-02 14:56 | CC:KNE | Kane Biotech Inc (2) | 0.065 | News Release200 | Kane Biotech rolls out revyve anti-microbial wound gel |
| 2023-09-19 19:20 | CC:KNE | Kane Biotech Inc (2) | 0.08 | Miscellaneous270 | Kane Biotech five million warrants for debt |
| 2023-09-18 17:52 | CC:KNE | Kane Biotech Inc (2) | 0.07 | Private Placement250 | Kane Biotech 6.25-million-share private placement |
| 2023-09-12 15:42 | CC:KNE | Kane Biotech Inc (2) | 0.075 | News Release200 | Kane Biotech closes $500,000 private placement |
| 2023-08-29 17:05 | CC:KNE | Kane Biotech Inc (2) | 0.08 | News Release200 | Kane Biotech loses $967,905 in Q2 |
| 2023-08-29 10:49 | CC:KNE | Kane Biotech Inc (2) | 0.08 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-08-29 10:43 | CC:KNE | Kane Biotech Inc (2) | 0.08 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-22 11:04 | CC:KNE | Kane Biotech Inc (2) | 0.08 | News Release200 | Kane Biotech to release Q2 2023 results Aug. 29 |
| 2023-08-03 16:32 | CC:KNE | Kane Biotech Inc (2) | 0.08 | News Release200 | Kane Biotech arranges $500,000 private placement |
| 2023-08-02 11:39 | CC:KNE | Kane Biotech Inc (2) | 0.085 | News Release200 | Kane Biotech puts Stem animal health business on block |
| 2023-06-23 17:43 | CC:KNE | Kane Biotech Inc (2) | 0.095 | News Release200 | Kane Biotech issues 9.7 million restricted share units |
| 2023-05-29 10:41 | CC:KNE | Kane Biotech Inc (2) | 0.10 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-29 10:41 | CC:KNE | Kane Biotech Inc (2) | 0.10 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-25 17:03 | CC:KNE | Kane Biotech Inc (2) | 0.11 | News Release200 | Kane Biotech loses $1.24-million in Q1 2023 |
| 2023-05-25 11:05 | CC:KNE | Kane Biotech Inc (2) | 0.11 | News Release200 | Kane Biotech receives FDA clearance for coactiv+ |
| 2023-05-25 10:47 | CC:KNE | Kane Biotech Inc (2) | 0.11 | Resume Trading385 | Kane Biotech to resume at 8:15 a.m. PT |
| 2023-05-25 08:48 | CC:KNE | Kane Biotech Inc (2) | 0.11 | Halt Trading170 | Kane Biotech halted at the open |
| 2023-05-18 16:33 | CC:KNE | Kane Biotech Inc (2) | 0.11 | News Release200 | Kane Biotech to release Q1 2023 results May 25 |